
Carmen Bergom, MD, PhD
Identification of new targets to improve tumor radiation effectiveness and to protect normal tissues such as the heart from radiation injury
- Email: acbergom@wustl.edu

Kelly L. Bolton, PhD, MD
The interplay between inherited genetic variation, environmental factors, and acquired mutations in shaping the earliest stages of carcinogenesis
- Email: bolton@wustl.edu

Nicole Brossier, MD, PhD
pediatric, glioma, obesity, neurofibromatosis, neurodevelopment
- Email: nbrossier@wustl.edu

Jian Campian, MD, PhD
Immunotherapy, brain tumor, spinal cord tumor, high grade gliomas
- Email: jcampian@dom.wustl.edu

Feng Chen, PhD
genetic determinants and pathogenic mechanisms of urogenital diseases with the goal of improving diagnostic and therapeutic strategies targeting these diseases
- Email: fchen@wustl.edu

Jaebok Choi, PhD
Understanding T cells and immunoregulatory networks in GvHD and GvL for the treatment of hematopoietic malignancies
- Email: jchoi25@wustl.edu

Francesca Ferraro, MD, PhD
We use both mouse models and patient samples of acute myloid leukemia to understand leukemogenesis and to identify novel therapeutic targets.
- Email: ferrarof@wustl.edu

Alireza Ghanbarpour, PhD
AAA proteases, cryo-EM, biochemistry, mass spectrometry, structural biology, microbiology, mitochondria
- Email: alirezag@wustl.edu

Matthew Goodwin, MD, PhD
Metabolism of cancer, targeting tumor metabolism by blocking metabolic pathways
- Email: matthewlgoodwin@wustl.edu

Abby Green, MD
identify factors within DNA damage response signaling pathways that represent therapeutic vulnerabilities in order to develop new treatment options for children with cancer
- Email: abby.green@wustl.edu

Eric Greer, PhD
Epigenetics, Transgenerational, Imprinting, Evolution, Multicellularity, Cancer, Tumorigenesis, Epitranscriptomics
- Email: ericg@wustl.edu

Joseph Ippolito, MD, PhD
cancer, metabolism, imaging, sex differences, glioblastoma
- Email: ippolitoj@wustl.edu

Yoon-A Kang, PhD
Hematopoietic stem cells, Multipotent progenitor, Cell fate decision, Lineage specification
- Email: yoonakang@wustl.edu

Vaishali Kapoor, PhD
Cancer, Targeted therapy, Antibodies, Cell signaling, antibody-drug conjugates, drug resistance
- Email: vkapoor@wustl.edu

John Krais, PhD
DNA damage response and how to apply new discoveries to the treatment of cancer
- Email: krais@wustl.edu

Kiran Mahajan
Epigenetics, prostate cancer, transcriptomics, small molecule therapeutics, radioresistance, DNA damage signaling, and tumor-immune dynamics
- Email: kiranm@wustl.edu

M. Benjamin Major, PhD
proteomics, functional genomics, lung cancer, signal transduction, WNT, oxidative stress
- Email: bmajor@wustl.edu

Stephanie Markovina, MD, PhD
prognosis and response to radiation therapy, therapeutic targets for cervical and anal cancers
- Email: smarkovina@wustl.edu

Melissa Mavers, MD, PhD
immune regulation of graft-versus-host disease (GVHD), a debilitating and potentially fatal complication of hematopoietic stem cell transplantation (HSCT)
- Email: mmmavers@wustl.edu

Michael Meers, PhD
Epigenetics, Chromatin, Genomics, Gene Regulation, Cell fate, Transcription Factors
- Email: meers@wustl.edu

Camilo Molina, MD, FAANS
spinal deformity, spinal oncology, improving surgical safety, efficacy, and efficiency
- Email: cmolina@wustl.edu

Benjamin Northrup, MD
Cartilage MRI, sustainability in Radiology, image-guided ablation of musculoskeletal tumors, musculoskeletal interventional radiology
- Email: northrupb@wustl.edu

Hua Pan, PhD
identifying determinant protein domains governing voltage sensing and gate opening mechanisms of the cardiac IKs channel, which is a pathological determinant of the high mortality “Long QT Syndrome”
- Email: hpan@wustl.edu

Gary Patti, PhD
To understand the metabolic crosstalk between cells and tissues in disease models such as cancer by using isotopes and metabolomics
- Email: gjpattij@wustl.edu

Guangyong Peng, PhD
Role of Senescent T cells in tumor and neurodegeneration; tumor-associated regulatory T cells (Tregs) in suppression of anti-tumor immunity, Toll-like receptor (TLR) ligands and other immunomodulators; metabolic and epigenetic reprogramming of T cells for immunotherapy
- Email: pengg@wustl.edu

Patrícia Ribeiro Pereira, PhD
Molecular imaging tools to understand tumor biology and response to therapies
- Email: ribeiropereirap@wustl.edu

Joshua B. Rubin, MD, PhD
tumor biology, signal transduction, stem cells, neural development, sexual dimorphism, circadaian rhythm, chemokines, cAMP
- Email: Rubin_J@wustl.edu

Julie Schwarz, MD, PhD
Gynecologic cancers, thyroid cancer, molecular imaging
- Email: jschwarz@wustl.edu

Jieya Shao, PhD
targeting cancer-specific abnormalities, biology of cancer-relevant cellular proteins, breast cancer
- Email: shao.j@wustl.edu

Girdhar Sharma, PhD
Epigenetics, stem cell radiation response, chromatin and DNA damage response, apoptosis, DNA repair, post-translational histone modifications, oncogenesis.
- Email: sharma@wustl.edu

Monica Shokeen, PhD
Antigen-4 (VLA-4) targeted PET radiopharmaceuticals, multiple myeloma, hematopoietic progenitor cells (HPCs), PET, MRI and Optical imaging techniques
- Email: mshokeen@wustl.edu

Jessica Silva-Fisher, PhD
Long non-coding RNAs and RNA modifications in cancer metastasis and relapse
- Email: silvajm@wustl.edu

Alexander Stegh, PhD
pathogenesis of glioblastoma, tumor-mediated immune suppression, nanotechnologies
- Email: stegh@wustl.edu

Rui Tang, PhD
cancer metastasis; tumor microenvironment, cancer immunology, CRISPR screen, quantitative biology
- Email: ruit@wustl.edu

Aayushi Uberoi, PhD
skin microbiome, skinomics, metagenomics, host-microbial genetics
- Email: uberoi@wustl.edu

Priyanka Verma, Ph.D.
The Verma lab studies the causes and consequences of DNA damage in cancers
- Email: vermap@wustl.edu

Max Wattenberg, PhD
pancreatic cancer, immunotherapy, myeloid cells, tumor microenvironment, CRISPR screening
- Email: wattenberg@wustl.edu

Max Wattenberg, MD
Pancreatic cancer, immunotherapy, myeloid cells, CRISPR screening, translational research
- Email: wattenberg@wustl.edu

Zhongsheng You, PhD
Cancer, DNA damage response, RNA surveillance, cell cycle, chromatin, laser micro-irradiation, Xenopus egg extracts, imaging, genetically-encoded reporters
- Email: zyou@wustl.edu

Mohamed Zayed, MD, PhD
mechanisms that influence arterial collateral formation and peripheral arterial atheroprogression in the setting of diabetes
- Email: zayedm@wustl.edu